title: Serum progesterone and luteinizing hormone in ewes treated with PGF 2 alpha during mid-gestation and gonadotropin releasing hormone after parturition.
abstract: Two studies were conducted to determine if postpartum (PP) reproductive function could be enhanced in ewes by PGF2 alpha during mid-gestation (Trial 1) and GnRH within 10 days PP (Trial 2). Trial 1 utilized 31 ewes (mean body weight = 84 kg) assigned to two treatment groups to receive (I.M.) either saline (control, n = 17) or PGF2 alpha (0.14 mg/kg body weight, n = 14) on day 74 of gestation. Results from the first study indicated success in regressing the corpus luteum (CL) of pregnancy as indicated by decreased serum progesterone (P4, P < 0.05) by 24 hours after treatment. In addition, by 20 days after treatment, serum luteinizing hormone (LH) concentrations in treated ewes were higher (P < 0.01) than in controls. However, ovarian activity was not re-established by 30 days PP in this study. In Trial 2, 35 ewes (mean body weight = 79 kg) were randomly assigned to one of four groups: no treatment (controls, n = 9), PGF2 alpha (no GnRH, n = 9), GnRH (no PGF2 alpha n = 9) or both PGF2 alpha and GnRH (n = 9). The PGF2 alpha-treated animals received 0.14 mg PGF2 alpha/kg body weight (I.M.) on day 73 of gestation and GnRH-treated ewes received 50 micrograms GnRH (I.M.) on days 2, 6, and 10 PP. As in Trial 1, P4 concentrations in PGF2 alpha-treated ewes were lower (P < 0.02) than in control ewes by 24 hours after treatment. Progesterone remained lower in PGF2 alpha-treated animals through day 116 of gestation. However, no differences were detected (P > 0.65) in LH concentrations between the two groups in this same period. Likewise, no differences were observed (P > 0.32) in LH concentrations between the PGF2 alpha-treated and control ewes on days 2, 6, and 10 PP. However, elevated (P < 0.07) LH concentrations were noted in ewes receiving 50 micrograms GnRH compared with ewes not receiving GnRH. In addition, area under the LH curve (AUC) was greater (P < 0.01) for GnRH-treated animals on days 2, 6, and 10 PP and LH AUC increased over the PP period in GnRH-treated ewes. Three of eight ewes receiving both PGF2 alpha and GnRH treatments had ovarian activity within 30 days PP as indicated by P4 concentrations above 1 ng/ml while no other ewes had ovarian activity during this time period.
authors.affiliation: Department of Animal and Range Sciences, New Mexico State University, Las Cruces 88003.
authors.forename: J W
authors.initials: JW
authors.lastname: Campbell
authors.forename: D M
authors.initials: DM
authors.lastname: Hallford
authors.forename: M E
authors.initials: ME
authors.lastname: Wise
mesh_terms: D000818:Animals; D015237:Dinoprost / Q000494:pharmacology*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000097:blood*; D007743:Labor, Obstetric / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood*; D011247:Pregnancy; D011374:Progesterone / Q000097:blood*; D012756:Sheep
chemical_list: D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D007986:Luteinizing Hormone; D015237:Dinoprost